Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
See Latest ArticlesRisk of cardiovascular outcomes in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 07/01/09
Schneider C et al. - The study provides evidence that estradiol/dydrogesterone use of several months to a few years is not associated with a higher risk of cardiovascular events than use of other HRT.
Related Articles
Risk of gynecological cancers in users of estradiol/dydrogesterone or other HRT preparations
Climacteric, 11/16/09
Relevance Score: 80%
Today in Maternal Fetal Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
The complete three-vessel view in prenatal detection of congenital heart defects
Prenatal Diagnosis, 11/25/09
What impact does pregnancy have on anxiety about health
Journal of Psychosomatic Obstetrics and Gynecology , 11/25/09
Brain Microstructure Is Related to Math Ability in Children With Fetal Alcohol Spectrum Disorder
Alcoholism, 11/25/09
Today in Repro Endo - Infertility...keeping you current
Receive free subspecialty "5-minute updates" via email
Higher interleukin-18 and mannose-binding lectin are present in uterine lumen of patients with unexplained infertility
Reproductive BioMedicine Online, 11/25/09
How common is polycystic ovary syndrome in recurrent miscarriage
Reproductive BioMedicine Online, 11/24/09
Comparison of effects of 3 mg drospirenone plus 20 ug ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome
Fertility and Sterility, 11/24/09
Sponsor
Article Search
Sponsor